Histological study of the drug PEG-Filstim sub-acute toxicity

Journal Title: Фармацевтичний журнал - Year 2017, Vol 3, Issue 3

Abstract

One of the critical steps in development of safe and efficient drugs during their pre-clinical trials are toxicity studies. Therefore, the aim of our work was to study PEG-Filstim toxic effects on animal internal organs and tissues. Toxicity study of PEG-Filstim was performed in 50 white wild-type rats of both sexes with body weight of 170 to 230 g on daily (28 days) subcutaneous administration in the doses of 0.5, 1.0 and 2.0 mg/kg. In all groups of animals, after completing the experiment careful pathomorphologic and histological examination was performed. PEG-Filstim has been shown to possess no toxic effects on internal organs of laboratory rats and does not cause specific changes in the heart, kidneys and mucous coat of stomach on daily subcutaneous administration in the doses of 0.5, 1.0, and 2.0 mg/kg within 28 days. In the maximum applied dose of 2.0 mg/kg, the studied drug causes pronounced acute splenic hyperplasia, related to hyper-proliferation of the reticular tissue, leads to functional strain of the liver due to formation of hematopoietic foci in it, as well as impaired integrity of the respiratory epithelium and congestive signs in the lungs, swelling of the brain tissues, abnormalities in the gray matter structure and hyperemia of the brain vessels. These effects were not observed in the animals, to which the drug was administered in the doses of 0.5 and 1.0 mg/kg. Administration of PEG-Filstim (in all studied doses) results in increasing the size of the ankle joint in rats, which is related to hyper-proliferation of the reticular tissue, leading to bone defect formation in the form of perforation with subsequent filling the periosteum with reticular tissue and formation of hematopoietic foci within its boundaries.

Authors and Affiliations

V. L. Karbovskyy, I. A. Shevchuk, O. V. Kurkina, T. Ye. Makovska

Keywords

Related Articles

The substantiation of plant raw materials ratio and determination of raw materials technological parameters in the development of complex tincture for the telogen effluvium treatment

Telogen effluvium is the most common form of diffuse alopecia in women due to concomitant somatic pathology and adverse exogenous factors. Pharmacotherapy of the disease requires the use of active substances that should...

Automation of electronic system for the formation of bibliography of scientific works in higher medical educational establishments of Ukraine

Establishments, where workers accomplish scientific investigation, give information in reporting data about conducted research in qualitative and quantitative forms, indicating references to published results of investig...

Technology administration active substance in the ointment base

The problem of expanding the range of medicines that are used for the topical treatment of wound process, remains an important challenge for practical military medicine. In this aspect, there are topical ointments combin...

Forensic and pharmaceutical study of abuse and developing the principles of reducing the demand for psychoactive substances of different classification and regulatory groups

The article by forensic pharmaceutical study found that illicit substance abuse of different classification and regulatory groups is one of the most difficult problems of today, which is acute to provided the countries o...

Legal and ethical basis of the interaction of provisors (doctors) with public control subjects of the quality assurance of medicines at the stages of their sale and medical use

Modern domestic public activism as a phenomenon that has become widespread relatively recently, creates new challenges for the pharmaceutical sector of the health care branch. Legal and ethical aspects of the interaction...

Download PDF file
  • EP ID EP556058
  • DOI 10.32352/0367-3057.3-4.17.09
  • Views 76
  • Downloads 0

How To Cite

V. L. Karbovskyy, I. A. Shevchuk, O. V. Kurkina, T. Ye. Makovska (2017). Histological study of the drug PEG-Filstim sub-acute toxicity. Фармацевтичний журнал, 3(3), 80-88. https://europub.co.uk/articles/-A-556058